Pharmaceutical regulatory data, drug approvals & compliance tracking
Home › Compliance › Import Export
This page provides comprehensive data and analytics for import export compliance guide. Our database is updated regularly to ensure accuracy and relevance. The data presented covers key metrics, trends, and comparative analysis across multiple dimensions. Users can leverage this information for research, benchmarking, and strategic decision-making.
Historical data is available for trend analysis, allowing users to identify patterns and forecast future developments. The platform supports custom date ranges and filtering options for deeper analysis. Industry experts recommend monitoring these metrics on a monthly basis to stay ahead of market shifts. Our data shows significant movement in several key indicators over the past quarter.
This page is part of the FDA News data platform, which offers comprehensive coverage across related categories. Navigate using the links above to explore other sections.
| Requirement | Category | Deadline | Penalty | Reference |
|---|---|---|---|---|
| Annual registration | Mandatory | Dec 31 | $15,000 | 21 CFR 207 |
| Adverse event reporting | Mandatory | 15 days | Warning letter | 21 CFR 314 |
| Label review | Pre-market | Before launch | Seizure | 21 CFR 201 |
| GMP audit | Every 2 years | Ongoing | Import alert | 21 CFR 211 |
| Record keeping | Mandatory | Ongoing | $10,000/day | 21 CFR 211 |
Data updated continuously. Last refresh: May 11, 2026 14:30 UTC.
